FACEBOOK  |  TWITTER  |  INSTAGRAM  |  LINKEDIN  |  Contact Us  |  Site Map
Get Involved

Marco L. Davila, MD, PhD

Marco L. Davila, MD, PhD
University of South Florida
*Associate Member*

What is your current professional status?

Associate Member

What is your work setting (i.e. academic institution, government organization (i.e. FDA, NIH, etc.), bio-industry/pharmaceutical company, etc.)

Academic Cancer Center

What is your scientific area of research?

Adoptive T cell therapy.

Why do you want to be a mentor?

I enjoy helping out folks that are going through their development as an academic researcher.

As a mentor, what are you hoping to gain from this experience?

Meet new investigators.       

How important are the following in the selection of a mentee: (1 – 5 scale, 1 = most important, 5 = least important)

            a. Compatibility of Scientific Specialties - 2
            b. Geographic Location - 3
            c. Professional Status / Success - 3
            d. Compatibility of Career Path - 2
            e. Communication Style - 3

Summarized in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy.

Marco Davila enrolled in the Medical Scientist Training Program and obtained his MD and PhD degrees. His PhD was in Immunology and his work involved the regulation of mouse B cell development by recombination signal sequences. After graduating Duke, Marco went to New York City for his medical training. He completed his internal medicine training at New York Presbyterian/Weill Cornell and medical oncology training at MSKCC. As a fellow at MSKCC, Marco worked with Michel Sadelain and Renier Brentjens of the Center for Cell Engineering and Leukemia Service at MSKCC. He developed a pre-clinical mouse model of B cell acute lymphoblastic leukemia (B-ALL) that validated it as a target for T cells genetically modified with chimeric antigen receptors (CARs). This led to the development of a clinical protocol for adults with relapsed/refractory B-ALL, which he served as the principal investigator. He has now moved to the Moffitt Cancer Center where he continues to manage patients with hematologic malignancies, but also has established his own laboratory that will focus on the development of new CARs as well as pre-clinical studies to understand CAR T cell biology.

Click here to view Marco Davila's CV.